Evidence map›Paper›PMID 27796592›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2016

The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.

Cheng Zhang, Shang-Hai Lai, Chuan-Chuan Zeng, Bing Tang, Dan Wan, De-Gang Xing, Yun-Jun Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Cheng ZhangSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Shang-Hai LaiSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Chuan-Chuan ZengSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Bing TangSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Dan WanSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
De-Gang XingSchool of Basic Science, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China. degangxing@126.com.
Yun-Jun LiuSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China. lyjche@163.com.
Guangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new ligand BTCP and its iridium(III) complex [Ir(ppy)

Indexed as

A549 CellsAnimalsAntineoplastic AgentsApoptosisAutophagyBlotting, WesternCaspasesCell Cycle CheckpointsCell LineCell Line, TumorCell ProliferationCoordination ComplexesDose-Response Relationship, DrugHeLa CellsHep G2 CellsHumansAntineoplastic AgentsCaspasesCoordination ComplexesIridiumProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesApoptosisAutophagyBcl-2 family proteinsCell invasionIr(III) complex

Identifiers

PMID27796592
OpenAlexW2542867913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.